V014-0947 Screening compound: 2-[8-(2,2-diphenylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide

V014-0947 Screening compound: 2-[8-(2,2-diphenylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide
V014-0947 Screening compound: 2-[8-(2,2-diphenylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-0947
2-[8-(2,2-diphenylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-0947

Molecular Formula

C32H36N4O4 (C32 H36 N4 O4)

Compound Name

2-[8-(2,2-diphenylacetyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide

IUPAC name

2-[8-(22-diphenylacetyl)-4-oxo-1-phenyl-138-triazaspiro[4.5]decan-3-yl]-N-(2-methoxyethyl)acetamide

SMILES

COCCNC(CN(CN(C1(CC2)CCN2C(C(c2ccccc2)c2ccccc2)=O)c2ccccc2)C1=O)=O

InChI

InChI=1S/C32H36N4O4/c1-40-22-19-33-28(37)23-35-24-36(27-15-9-4-10-16-27)32(31(35)39)17-20-34(21-18-32)30(38)29(25-11-5-2-6-12-25)26-13-7-3-8-14-26/h2-16,29H,17-24H2,1H3,(H,33,37)

InChI Key

DYMLMUBXNJNFMF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD10458829

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

540.66

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.613

Distribution Coefficient, logD

3.613

Water Solubility, LogSw

-3.54

Polar Surface Area

69.560

Acid Dissociation Constant (pKa)

14.49

Base Dissociation Constant (pKb)

1.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.40

V014-0947 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

DGK Inhibitors Library (10558 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V014-0947 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-0947?
Check Price and Availability of V014-0947, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-0947 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-0947
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-0947
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-0947 available by request